UNSPSC 51332804: Butaperazine

This classification denotes a dopamine antagonist with the molecular formula C24H31N3OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TXP4T9106S, chemically known as 1-butanone, 1-(10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazin-2-yl)- but generally known as butaperazine, which bears US NIH Compound Identifier 12598. Butaperazine most often comes in base and maleate forms. European Medicines Agency schedules Butaperazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06007MIG.

UNSPSC 51332804 Butaperazine is a Commodity code that in recent state and local procurement activity covers pharmaceutical procurement for public health and community safety initiatives. The single recent opportunity on record shows state and local governments buying naloxone and drug deactivation systems through competitive bidding processes tied to community health operations and opioid-response programming. Issuing bodies sourcing under this code include county health departments and community health agencies managing pharmaceutical inventories and harm-reduction initiatives.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid process required electronic submission through the county's e-Procurement Portal, with a response deadline of July 26, 2023, at 2:00 pm. The contract carried a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify and drug-free workplace certification requirements, and potential FEMA funding with associated federal compliance obligations. Limited recent activity under this code limits geographic characterization; the single tracked opportunity is in Florida.